These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 27010858)
61. XIAP gene downregulation by small interfering RNA inhibits proliferation, induces apoptosis, and reverses the cisplatin resistance of ovarian carcinoma. Ma JJ; Chen BL; Xin XY Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):222-6. PubMed ID: 19758744 [TBL] [Abstract][Full Text] [Related]
62. Sohlh2 inhibits human ovarian cancer cell invasion and metastasis by transcriptional inactivation of MMP9. Zhang H; Hao C; Wang Y; Ji S; Zhang X; Zhang W; Zhao Q; Sun J; Hao J Mol Carcinog; 2016 Jul; 55(7):1127-37. PubMed ID: 26153894 [TBL] [Abstract][Full Text] [Related]
63. MicroRNA-145 targets TRIM2 and exerts tumor-suppressing functions in epithelial ovarian cancer. Chen X; Dong C; Law PT; Chan MT; Su Z; Wang S; Wu WK; Xu H Gynecol Oncol; 2015 Dec; 139(3):513-9. PubMed ID: 26472353 [TBL] [Abstract][Full Text] [Related]
64. Reduced Klotho expression contributes to poor survival rates in human patients with ovarian cancer, and overexpression of Klotho inhibits the progression of ovarian cancer partly via the inhibition of systemic inflammation in nude mice. Yan Y; Wang Y; Xiong Y; Lin X; Zhou P; Chen Z Mol Med Rep; 2017 Apr; 15(4):1777-1785. PubMed ID: 28259911 [TBL] [Abstract][Full Text] [Related]
65. R-Ketorolac Targets Cdc42 and Rac1 and Alters Ovarian Cancer Cell Behaviors Critical for Invasion and Metastasis. Guo Y; Kenney SR; Muller CY; Adams S; Rutledge T; Romero E; Murray-Krezan C; Prekeris R; Sklar LA; Hudson LG; Wandinger-Ness A Mol Cancer Ther; 2015 Oct; 14(10):2215-27. PubMed ID: 26206334 [TBL] [Abstract][Full Text] [Related]
66. A Novel Pharmacologic Activity of Ketorolac for Therapeutic Benefit in Ovarian Cancer Patients. Guo Y; Kenney SR; Cook L; Adams SF; Rutledge T; Romero E; Oprea TI; Sklar LA; Bedrick E; Wiggins CL; Kang H; Lomo L; Muller CY; Wandinger-Ness A; Hudson LG Clin Cancer Res; 2015 Nov; 21(22):5064-72. PubMed ID: 26071482 [TBL] [Abstract][Full Text] [Related]
67. Expression of ARHGAP10 correlates with prognosis of prostate cancer. Gong H; Chen X; Jin Y; Lu J; Cai Y; Wei O; Zhao J; Zhang W; Wen X; Wang Y; Chen W Int J Clin Exp Pathol; 2019; 12(10):3839-3846. PubMed ID: 31933772 [TBL] [Abstract][Full Text] [Related]
68. Overexpression of TMEM158 contributes to ovarian carcinogenesis. Cheng Z; Guo J; Chen L; Luo N; Yang W; Qu X J Exp Clin Cancer Res; 2015 Aug; 34(1):75. PubMed ID: 26239324 [TBL] [Abstract][Full Text] [Related]
69. miR-133 is a key negative regulator of CDC42-PAK pathway in gastric cancer. Cheng Z; Liu F; Wang G; Li Y; Zhang H; Li F Cell Signal; 2014 Dec; 26(12):2667-73. PubMed ID: 25152372 [TBL] [Abstract][Full Text] [Related]
70. miR-148b-3p inhibits gastric cancer metastasis by inhibiting the Dock6/Rac1/Cdc42 axis. Li X; Jiang M; Chen D; Xu B; Wang R; Chu Y; Wang W; Zhou L; Lei Z; Nie Y; Fan D; Shang Y; Wu K; Liang J J Exp Clin Cancer Res; 2018 Mar; 37(1):71. PubMed ID: 29587866 [TBL] [Abstract][Full Text] [Related]
71. srGAP1 mediates the migration inhibition effect of Slit2-Robo1 in colorectal cancer. Feng Y; Feng L; Yu D; Zou J; Huang Z J Exp Clin Cancer Res; 2016 Dec; 35(1):191. PubMed ID: 27923383 [TBL] [Abstract][Full Text] [Related]
72. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression. Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143 [TBL] [Abstract][Full Text] [Related]
73. Suppression of human ovarian carcinoma metastasis by the metastasis-suppressor gene, BRMS1. Zhang S; Lin QD; DI W Int J Gynecol Cancer; 2006; 16(2):522-31. PubMed ID: 16681721 [TBL] [Abstract][Full Text] [Related]
74. DLC-1 tumor suppressor regulates CD105 expression on human non-small cell lung carcinoma cells through inhibiting TGF-β1 signaling. Zhang K; Na T; Ge F; Yuan BZ Exp Cell Res; 2020 Jan; 386(2):111732. PubMed ID: 31770531 [TBL] [Abstract][Full Text] [Related]
75. Rac GTPase activating protein 1 promotes oncogenic progression of epithelial ovarian cancer. Wang C; Wang W; Liu Y; Yong M; Yang Y; Zhou H Cancer Sci; 2018 Jan; 109(1):84-93. PubMed ID: 29095547 [TBL] [Abstract][Full Text] [Related]
76. PDZ and LIM domain protein 4 suppresses the growth and invasion of ovarian cancer cells via inactivation of STAT3 signaling. Jia Y; Shi H; Cao Y; Feng W; Li M; Li X Life Sci; 2019 Sep; 233():116715. PubMed ID: 31376371 [TBL] [Abstract][Full Text] [Related]
77. CDC42 Regulates Cell Proliferation and Apoptosis in Bladder Cancer via the IQGAP3-Mediated Ras/ERK Pathway. Li G; Wang Y; Guo XB; Zhao B Biochem Genet; 2022 Dec; 60(6):2383-2398. PubMed ID: 35412170 [TBL] [Abstract][Full Text] [Related]
78. High level of CFTR expression is associated with tumor aggression and knockdown of CFTR suppresses proliferation of ovarian cancer in vitro and in vivo. Xu J; Yong M; Li J; Dong X; Yu T; Fu X; Hu L Oncol Rep; 2015 May; 33(5):2227-34. PubMed ID: 25738998 [TBL] [Abstract][Full Text] [Related]
79. ARHGAP10 Inhibits the Proliferation and Metastasis of CRC Cells via Blocking the Activity of RhoA/AKT Signaling Pathway. Liu L; Xie D; Xie H; Huang W; Zhang J; Jin W; Jiang W; Xie D Onco Targets Ther; 2019; 12():11507-11516. PubMed ID: 31920339 [TBL] [Abstract][Full Text] [Related]
80. Rho GTPase-activating protein 10 (ARHGAP10/GRAF2) is a novel autoantibody target in patients with autoimmune encephalitis. Jarius S; Komorowski L; Regula JU; Haas J; Brakopp S; Wildemann B J Neurol; 2022 Oct; 269(10):5420-5430. PubMed ID: 35624318 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]